As a man of science, I've learned to perform good first-pass estimates based on back of napkin math...
A few necessary, but fairly good assumptions:
1. the number of 150K survivors with metastatic (stage IV) BC is correct
2. constant diagnosis & death rates (fairly correct), so new cases of metastatic cancer (IN) equals deaths (OUT)
3. only those with metastatic die of the disease (correct)
4. assume identical survival rates (actually, 5-yr BC is 22%, 5-yr PC is 29%, for metastatic disease)
5. linear survival rates (probably good estimate for metastatic disease with no cure)
Assuming those similarities, a first estimate would be that the multiplication rate for the living is 150K living / 41K deaths (which is the number of BC deaths) = 3.6 living/deaths. Then, 3.6 living/deaths* 26K deaths (PC deaths) = 95K living.
Higher survival of PC (see assumption 4.) would increase that number.
Estimating
about 100K men living with metastatic PC (in the US).
By contrast for scale, an estimated 2 million living men have been overtreated for PC in the US.
Post Edited (JackH) : 5/31/2017 2:46:02 PM (GMT-6)